The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Reach customers where they live, work, and scroll. With 665,386 unique visits in the past 28 days alone, timesleader.com stands as one of the most highly trafficked websites in Northeastern ...

Showcase your company news with guaranteed exposure both in print and online Following the announcement of a new Broncos stadium and Summit FC stadium, the DBJ will ...